Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beef Cattle Behavior Recognition Based on Nighttime Farm Videos via Spatio-Temporal Enhancement and Dynamic Fusion.

Animals : an open access journal from MDPI·2026
Same author

Dual-SAM/Al<sub>2</sub>O<sub>3</sub>-Nanoparticles Hole-Selective Stack With BCP/PEAI Passivation Enabling High Performance Inverted Perovskite Solar Cells.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Early supplementation with live combined <i>Bacillus subtilis</i> and <i>Enterococcus faecium</i>: association with feeding intolerance and gut microbiota composition in antibiotic-exposed preterm infants.

Frontiers in cellular and infection microbiology·2026
Same author

Misalignment Decoupling and Tilt-to-Length Suppression in a Micro-Actuated Beam Steering Mechanism via Nonlinear Cyclic Modulation.

Micromachines·2026
Same author

Tendon-Inspired, Fatigue-Resistant Conductive Organohydrogels via Solvent-Exchange-Assisted Mechanical Training.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Epoxide apparent exchange reaction for the precise synthesis of epoxy resins.

Nature communications·2026

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Hongming Zhang1, Jingwen Eh Tan2, Nan Zhang2

  • 1Frontage Laboratories, Exton, PA, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
PubMed
Summary
This summary is machine-generated.

Plasma pTau217 assays show promise for early Alzheimer's disease diagnosis. A head-to-head comparison of seven platforms revealed unique strengths, aiding clinical research and diagnostic application choices.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Area of Science:

  • Biomarker Discovery and Validation
  • Neurodegenerative Disease Diagnostics
  • Clinical Immunoassay Development

Background:

  • Plasma pTau217 is a key blood biomarker for early Alzheimer's disease (AD) detection, predicting onset decades before symptoms.
  • Numerous pTau217 assays exist, necessitating platform comparison for clinical utility.
  • This study compares seven pTau217 immunoassay platforms used in clinical trials and LDTs.

Purpose of the Study:

  • To conduct a head-to-head comparison of seven distinct plasma pTau217 immunoassay platforms.
  • To evaluate the performance characteristics of each platform for Alzheimer's disease diagnostics.
  • To provide guidance for selecting appropriate platforms for clinical research and LDT applications.

Main Methods:

  • Seven plasma pTau217 assays were tested on their respective manufacturer platforms: Beckman Coulter DxI 9000, Fujirebio Lumipulse G1200, AstrBio Ast-Sc-Semi, Quanterix Simoa HD-X, MSD Sector S600, Sigma SMCxPRO, and Alamar ARGO HT.
  • Assays were performed following manufacturer instructions.
  • Performance was evaluated across multiple parameters including accuracy, precision, sensitivity, throughput, and cost.

Main Results:

  • All seven tested pTau217 assays demonstrated good performance on their respective platforms.
  • Each platform exhibited unique features relevant to plasma pTau217 analysis.
  • Key performance metrics evaluated included hardware, software, sample preparation, automation, run time, accuracy, precision, detection range, sensitivity, correlation, cost, and maintenance.

Conclusions:

  • The seven evaluated pTau217 assays offer distinct advantages for plasma analysis.
  • The findings provide a valuable reference for selecting platforms for clinical research and LDT diagnostic applications.
  • This comparison aids in optimizing early Alzheimer's disease detection strategies.